Sygnature Discovery Limited
Chris Sleigh is a seasoned NMR Spectroscopy expert with extensive experience in the pharmaceutical and scientific industries. Currently serving as a Senior Principal Scientist at Sygnature Discovery since September 2017, Chris focuses on building NMR capability and has a keen interest in fast data acquisition, conformational analysis for drug design, and the characterization of active pharmaceutical ingredients. Prior roles include Principal Scientist (Consultant) at Sygnature Discovery and Senior NMR Spectroscopist at AstraZeneca, where Chris contributed to structure elucidation and the development of novel methodologies for in-situ NMR monitoring. Chris also has experience as a furniture maker, running a bespoke furniture business from September 2012 to July 2017. Educational qualifications include a BSc and DPhil in Chemistry from the University of York.
This person is not in any teams
This person is not in any offices
Sygnature Discovery Limited
2 followers
Sygnature Discovery are a leading drug discovery CRO with expertise across a range of therapeutic and biological target classes. An expert partner in disciplines including Medicinal and Computational Chemistry, In Vitro and In Vivo Pharmacology, DMPK, supported by informatics.